Neurona Therapeutics
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
170 Harbor Way, South San Francisco, Cal...Website
www.neuronatherapeutics.comRevenue
$16.3 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
2
2
1
About Neurona Therapeutics
Neurona Therapeutics is a privately-held, clinical-stage biotherapeutics company focused on discovering and developing allogeneic neural cell therapies to treat chronic diseases of the nervous system. Neurona was founded by leading-edge neuroscientists and stem cell pioneers at the University of California, San Francisco. Based on nearly two decades of research, we believe that specific neural cell lineages have the unique ability to integrate and repair dysregulated neural circuits. We have built a robust regenerative medicine discovery platform and developed proprietary methods to manufacture specific types of fully-differentiated neuronal, glial, and gene-edited cell therapy candidates for targeted delivery into the damaged nervous system. Product manufacturing is performed in Neuronas cGMP facility. Our motivated and talented team of innovators is working to advance first-in-class cell therapy treatments for patients with significant unmet medical needs.Explore more
Neurona Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neurona Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Neurona Therapeutics launches new products
Click to see if Neurona Therapeutics had a recent Job posting/layoffs
Check out if Neurona Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Neurona Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Neurona Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Neurona Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Neurona Therapeutics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Neurona Therapeutics recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Neurona Therapeutics
Compare insights from companies similar to Neurona Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Neurona Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Neurona Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Neurona Therapeutics.
Neurona Therapeutics financials insights
Gather financial insights about Neurona Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series A
$28.7M
2020
Debt
$350K
2021
Unspecified
$41.5M
2024
Series E
$120M
2025
Other Financing Round
$102M
Neurona Therapeutics Tech Stack
A closer look at the technologies used by Neurona Therapeutics
Most Recent Scoops
Hiring Plans
Neurona Therapeutics has more open roles in Operations than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Neurona Therapeutics has more open roles in Operations than it has had at any time in the past 12 months. Areas of expertise include: Performance Management, Supply Chain, Inventory Control, Operational Excellence, Production Readiness, Continuous Improvement Process, and Cross-Functional Collaboration.
Hiring Plans
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Search, Medical Research, Pharmaceuticals
Neurona Therapeutics News & Media
UCB goes all in on epilepsy with $1.15bn acquisition of Neurona - BioXconomy
Belgian biopharmaceutical company UCB has agreed to acquire Neurona Therapeutics in a deal worth up to $1.15 billion.UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through regenerative science
Acquisition builds on UCB's 30-year heritage and leadership as an innovator in epilepsy and accelerates entry into next generation disease-modifying therapies. Lead investigational asset, NRTX-1001, a neuronal cell therapy, is being evaluated in phase I/II clinical trials for...Neurona Therapeutics Presents New Long-Term Clinical Data from NRTX-1001 Cell Therapy Trials at 2025 Annual Meeting of the American Epilepsy Society
Neurona Therapeutics Presents New Long-Term Clinical Data from NRTX-1001 Cell Therapy Trials at 2025 Annual Meeting of the American Epilepsy SocietyNeurona Therapeutics Appoints Dr. Eduardo Dunayevich as Chief Medical Officer
SAN FRANCISCO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for disorders of the nervous system, today announced the appointment of Eduardo Dunayevich, M.D., as Chief Medical Officer.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neurona Therapeutics
Sign Up For FreeTo access detailed company insights
Neurona Therapeutics is a privately-held, clinical-stage biotherapeutics company focused on discovering and developing allogeneic neural cell therapies to treat chronic diseases of the nervous system. Neurona was founded by leading-edge neuroscientists and stem cell pioneers at the University of California, San Francisco. Based on nearly two decade... Read More
